PharmaVoice Logo

Healthcare Leaders Hub

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

Pharma Tech

Aug 18, 2026, 10:29 AM

Updated UK guidance for finerenone introduces new treatment for HF patients

New guidance from NICE provide a framework for UK care providers using finerenone to manage the treatment of certain types of heart failure.

Pharma Tech

Aug 18, 2026, 10:02 AM

LEO outlays $435m for rights to Tanabe’s rare disease drug for sun-induced pain

Tanabe’s dersimelagon is already under FDA review having achieved positive Phase III results earlier this year.

Pharma Tech

Aug 18, 2026, 9:09 AM

Faeth’s PIKTOR plus paclitaxel combo gains FDA fast track status

Faeth Therapeutics has received fast track designation from the FDA for the PIKTOR with paclitaxel combination to treat advanced or recurrent endometrial cancer.

Express Pharma

Aug 18, 2026, 9:03 AM

ACG appoints Lalit Kasliwal as Group Chief Financial Officer

Kasliwal to lead global finance, governance, capital allocation and risk management as ACG expands its international presence The post ACG appoints Lalit Kasliwal as Group Chief Financial Officer appeared first on Express Pharma.

Express Pharma

Aug 18, 2026, 8:33 AM

An effective methodology for diabetes prediction in the case of class imbalance

Dr Vincent Hooper highlights how a machine learning methodology can improve diabetes prediction in clinical datasets affected by class imbalance The post An effective methodology for diabetes prediction in the case of class imbalance appeared first on Express Pharma.

PharmaShots

Aug 18, 2026, 8:30 AM

LEO Pharma to Acquire Global Rights to Tanabe Pharma’s Dersimelagon for ~$435M

Shots: Ref: Businesswire   |  Image:  LEO Pharma & Tanabe  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post LEO Pharma to Acquire Global Rights to Tanabe Pharma’s Dersimelagon for ~$435M appeared first on PharmaShots.

News

Latest industry coverage

Google News

Aug 18, 2026, 10:30 AM

Updated UK guidance for finerenone introduces new treatment for HF patients - Pharmaceutical Technology

Updated UK guidance for finerenone introduces new treatment for HF patients  Pharmaceutical Technology

Google News

Aug 18, 2026, 10:28 AM

Less Solvent, More Performance: The Next Generation of Agricultural Formulations - Agrolatam

Less Solvent, More Performance: The Next Generation of Agricultural Formulations  Agrolatam

Google News

Aug 18, 2026, 10:23 AM

Invesco Mutual Fund unveils India Pharma and Healthcare Fund - BioSpectrum India

Invesco Mutual Fund unveils India Pharma and Healthcare Fund  BioSpectrum India

Google News

Aug 18, 2026, 10:18 AM

Why licensing deals are a powerful source of growth in life sciences - EY

Why licensing deals are a powerful source of growth in life sciences  EY

Google News

Aug 18, 2026, 10:09 AM

Aizen inks collaboration to advance oral biologics - The Pharma Letter

Aizen inks collaboration to advance oral biologics  The Pharma Letter

Google News

Aug 18, 2026, 10:05 AM

LEO outlays $435m for rights to Tanabe’s rare disease drug for sun-induced pain - Pharmaceutical Technology

LEO outlays $435m for rights to Tanabe’s rare disease drug for sun-induced pain  Pharmaceutical Technology

Google News

Aug 18, 2026, 9:56 AM

Moving at the speed of pharma digitalisation: driving ROI from AI and digital tools - Pharmaceutical Technology

Moving at the speed of pharma digitalisation: driving ROI from AI and digital tools  Pharmaceutical Technology

Google News

Aug 18, 2026, 9:53 AM

Partnership-first approach: Inside Servier's Asia innovation strategy - BioXconomy

Partnership-first approach: Inside Servier's Asia innovation strategy  BioXconomy

Google News

Aug 18, 2026, 9:52 AM

Pharmaceutical industry priorities for the Health Data Research Service - The Association of the British Pharmaceutical Industry|ABPI

Pharmaceutical industry priorities for the Health Data Research Service  The Association of the British Pharmaceutical Industry|ABPI

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer